Siloxane Microcapsules for Probiotic Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for treating recurring Clostridium difficile infections, such as Fecal Microbiota Transplant, face challenges including limited donor availability, rigorous screening requirements, discomfort for patients, and potential transmission of opportunistic pathogens, as well as difficulties in culturing and delivering probiotic microbes effectively.
Innovation Solution
Development of microcapsules with novel siloxane-based membranes that enclose probiotic microbes, allowing for controlled delivery and growth, utilizing crosslinked polymers and silica or magnetite nanoparticles to maintain transport properties and stability, enabling effective restoration of the healthy microbiome.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If Fecal Microbiota Transplant is used to treat recurring CDI, then treatment efficacy is improved, but patient comfort deteriorates due to discomfort from colonoscopy or nasogastric tube procedures
Solution Approach 1:
The patent uses a flexible hydrogel membrane to encapsulate probiotic microbes, creating a soft, comfortable delivery system that can be administered orally without invasive procedures. The hydrogel shell protects the microbes while allowing patient comfort, eliminating the need for colonoscopy or nasogastric tube procedures while maintaining treatment efficacy.
2Reliability
If Fecal Microbiota Transplant is used to treat recurring CDI, then treatment efficacy is improved, but safety deteriorates due to potential transmission of opportunistic pathogens
Solution Approach 1:
The hydrogel membrane acts as a selective barrier that protects the patient from potential pathogens while allowing beneficial probiotic microbes to survive and colonize. The encapsulation system enables controlled delivery of therapeutic microbes without transmitting harmful organisms.
Solution Approach 2:
The hydrogel membrane contains porous structures with controlled pore sizes that allow selective permeation. This porous structure permits nutrients and signaling molecules to pass through while preventing the transmission of larger pathogenic organisms, ensuring safety while maintaining treatment efficacy.
3Ease of manufacture
If conventional culture methods are used for probiotic microbes, then ease of manufacture is improved, but reliability deteriorates due to difficulty in culturing without exact environmental conditions
Solution Approach 1:
The patent nests probiotic microbes within a protective hydrogel matrix, which is then encapsulated in a hydrogel membrane shell. This nested structure creates a controlled microenvironment that mimics the exact conditions required by fastidious microbes, enabling reliable culturing and delivery while simplifying manufacturing processes.
Solution Approach 2:
The hydrogel matrix serves as an intermediary between the probiotic microbes and the external environment. It provides the exact environmental conditions (moisture, nutrients, protective atmosphere) that fastidious microbes require, acting as a mediator that enables their survival and growth without complex culturing procedures.
4Reliability
If microcapsules with siloxane-based membranes are used for probiotic delivery, then reliability of probiotic delivery is improved, but device complexity increases
Solution Approach 1:
The patent employs composite hydrogel materials combining different polymer components to create a membrane with optimized properties. The siloxane-based hydrogel composite provides mechanical strength, controlled permeability, and biocompatibility, achieving reliable probiotic delivery while the composite nature allows tuning of properties to simplify the overall device design.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The microcapsules provide a safe and effective method for delivering probiotic microbes, reducing the risk of infection recurrence and improving patient comfort, while ensuring the stability and viability of the microbial community, thus addressing the limitations of existing treatments.
Implementation Method 1
novel siloxane-based membranes that maintains transport properties essential to communication and growth of microbes
Implementation Method 2
a membrane comprising a crosslinked polymer, wherein the polymer comprises siloxane units
Data Source
AI summary
The present disclosure relates to microcapsules, methods of using such microcapsules in the delivery of drugs and probiotic microbes to subjects in need thereof, and methods of using such microcapsules for in vitro culture of microbes. In particular, the microcapsules comprise novel siloxane-based membranes that maintains transport properties essential to communication and growth of microbes.